SHENZHEN XILANG E-COMMERCE CO., LTD. – Trademark Portfolio
Entity Type: 99
SHENZHEN XILANG E-COMMERCE CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SYLONG and MISISIPY. The owner is based in FUTIAN DIST., SHENZHEN.
2603U15,26F,XINHUA INSURANCE BLDG,NO.171
MINTIAN RD, FU'AN COMMUNITY, FUTIAN ST,
FUTIAN DIST., SHENZHEN 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN XILANG E-COMMERCE CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does SHENZHEN XILANG E-COMMERCE CO., LTD. have?
SHENZHEN XILANG E-COMMERCE CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does SHENZHEN XILANG E-COMMERCE CO., LTD. file in?
SHENZHEN XILANG E-COMMERCE CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 18 (Leather Goods), Class 10 (Medical Apparatus). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.
What are SHENZHEN XILANG E-COMMERCE CO., LTD.'s most well-known trademarks?
SHENZHEN XILANG E-COMMERCE CO., LTD.'s registered trademark portfolio includes well-known marks such as SYLONG and MISISIPY. These are among 2 currently registered trademarks in the portfolio.
What is SHENZHEN XILANG E-COMMERCE CO., LTD.'s trademark registration success rate?
SHENZHEN XILANG E-COMMERCE CO., LTD. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.